Controlled studies of metopimazine for the treatment of nausea and vomiting.
D000932:Antiemetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005472:Fluorouracil / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007540:Isonipecotic Acids / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D010640:Phenothiazines / Q000627:therapeutic use*; D010919:Placebos; D011346:Prochlorperazine / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology
D000932:Antiemetics; D007540:Isonipecotic Acids; D010640:Phenothiazines; D010919:Placebos; D005472:Fluorouracil; D011346:Prochlorperazine